Kenneth P. H. Pritzker

Founder at Rna Diagnostics, Inc.

Health Services

Health Technology

Profile

Kenneth P.
H.
Pritzker is the founder and director of RNA Diagnostics, Inc. which is founded in 2010.
He also held a director position at CareRx Corp.
in 2009.

Kenneth P. H. Pritzker active positions

Companies	Position	Start
Rna Diagnostics, Inc. Rna Diagnostics, Inc. Medical SpecialtiesHealth Technology Rna Diagnostics, Inc. operates as a cancer diagnostics company which builds a platform of prognostic biomarker tools to help improve the lives of patients undergoing chemotherapy. The firm develops prognostic biomarker tools to improve the lives of women undergoing chemotherapy for breast cancer. It provides The RNA Disruption Assay (RDA), which provides physicians with an evaluation of how individual patients are responding to chemotherapy. The company was founded by Kenneth P. H. Pritzker in 2010 and is headquartered in Toronto, Canada.	Founder	31/12/2009

All active positions of Kenneth P. H. Pritzker

Former positions of Kenneth P. H. Pritzker

Companies	Position	End
CARERX CORPORATION	Director/Board Member	24/06/2009

See the detail of Kenneth P. H. Pritzker's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kenneth P. H. Pritzker's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
CARERX CORPORATION	Health Services

Private companies	1
Rna Diagnostics, Inc. Rna Diagnostics, Inc. Medical SpecialtiesHealth Technology Rna Diagnostics, Inc. operates as a cancer diagnostics company which builds a platform of prognostic biomarker tools to help improve the lives of patients undergoing chemotherapy. The firm develops prognostic biomarker tools to improve the lives of women undergoing chemotherapy for breast cancer. It provides The RNA Disruption Assay (RDA), which provides physicians with an evaluation of how individual patients are responding to chemotherapy. The company was founded by Kenneth P. H. Pritzker in 2010 and is headquartered in Toronto, Canada.	Health Technology